The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
26-Jun-14
$2.9 billion
Target:
Firth Rixson Limited
Acquiror:
Alcoa Inc.
Advised Alcoa Inc. on the acquisition of Firth Rixson Limited, a leading provider of highly engineered rings, industrial forgings and specialized metal products primarily to the aerospace industry
10-Jan-14
$144 million
Target:
Residential property portfolio of Grainger plc
Acquiror:
Clifden Holdings Limited
Advised Grainger plc on the sale of a portfolio of 1,203 residential home reversion properties located across the UK to Clifden Holdings Limited
09-Sep-13
$1.2 billion
Target:
Sinclair Knight Merz
Acquiror:
Jacobs Engineering Group
Advised Sinclair Knight Merz, a leading projects firm, with global capability in strategic consulting, engineering and project delivery on its recommended merger with Jacobs Engineering
01-Aug-13
$62 million
Target:
Futuris Automotive
Acquiror:
Clearlake Capital
Advised Elders on the sale of Futuris Automotive, Australia’s largest automotive component manufacturer, to Clearlake Capital, a US based private equity firm
20-May-13
$8.5 billion
Target:
Warner Chilcott, plc
Acquiror:
Actavis, Inc.
Advised Actavis, Inc., a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, branded and biosimilar products on its acquisition of Warner Chilcott plc
01-May-13
$NA
Target:
Jeminex’s Industrial & Safety division
Acquiror:
Bunzl plc
Advised AMP Capital on the sale of Jeminex’s Industrial & Safety division, Australia’s second largest industrial and safety business with branches across Australia, to Bunzl plc
25-Apr-13
$3.8 billion
Target:
GrainCorp Limited
Acquiror:
Archer Daniels Midland Company
Advised GrainCorp Limited on the unsolicited takeover offer from Archer Daniels Midland Company, a global agribusiness that converts oilseeds, corn, wheat and cocoa into products for food, animal feed and energy uses
21-Dec-12
$75 million
Target:
Australian Portable Buildings
Acquiror:
Black Diamond Group Limited and WEQ Britco LP
Advised CHAMP Ventures on the sale of its portfolio company Australian Portable Buildings, a leading Australian manufacturer of customized modular buildings, to a consortium comprising Black Diamond Group and WEQ Britco
07-Dec-12
$43 million
Target:
Champion Flour Limited
Acquiror:
Nisshin Seifun Group Inc.
Advised Goodman Fielder, a leading Australian listed food company, on the sale of its New Zealand flour milling business, Champion Flour, to Nisshin Seifun Group Inc.
27-Sep-12
$268 million
Target:
Alesco Corporation Limited
Acquiror:
DuluxGroup Limited
Advised Alesco, a supplier of building products into the Australian and New Zealand markets, on the unsolicited takeover offer from DuluxGroup, a manufacturer and supplier of paints and other surface coatings, and home improvement and garden care products
28-Aug-12
$177 million
Target:
Goodman Fielder’s Australian and New Zealand edible fats and oils business (Integro)
Acquiror:
Graincorp
Advised Goodman Fielder, Australia’s leading listed food company, on the divestment of its Australian and New Zealand edible fats and oils business to a joint venture between Graincorp, an ASX listed international agribusiness company, and Gardner Smith
07-Mar-12
$256 million
Target:
Aperio Group
Acquiror:
Amcor Limited
Advised Catalyst Investment Managers on the sale of its portfolio company Aperio Group, Australasia’s leading manufacturer of flexible packaging products, to Amcor Limited, a global leader in packaging solutions
19-Dec-11
$1.6 billion
Target:
The Miller Group
Advised The Miller Group, the UK’s largest private homebuilder, on the recapitalization of its balance sheet comprising a substantial new equity capital raising and a significant debt for equity swap
21-Nov-11
$689 million
Target:
iNova Pharmaceuticals
Acquiror:
Valeant Pharmaceuticals
Advised Archer Capital and Ironbridge Capital on the sale of iNova Pharmaceuticals, a leading pharmaceuticals company that sells and distributes a range of prescription and over-the-counter products in Australia, New Zealand, Asia and Southern Africa, to Valeant Pharmaceuticals
10-Nov-11
$318 million
Target:
MSF Sugar
Acquiror:
Mitr Phol Group
Advised MSF Sugar, Australia’s third largest producer and second largest exporter of sugar, on an acquisition proposal from Mitr Phol Sugar Corp. of Thailand at an offer value of ~31% premium to previous close
30-Jun-11
$1.7 billion
Target:
Minerva plc
Acquiror:
Jupiter Properties (owned by AREA Property Partners and Delancey Real Estate Asset Mgmt)
Advised Minerva plc, a property investment and development company, on a recommended offer from a consortium consisting of AREA Property Partners and Delancey Real Estate Asset Management
26-May-11
$192 million
Target:
Centrebet International Limited
Acquiror:
Sportingbet plc
Advised Centrebet International, a leading International online wagering and gaming operator on the recommended cash offer by Sportingbet plc
13-May-11
$NA
Target:
Bionomics Ltd
Advised Bionomics Ltd, in relation to the tender process run by Bionomics’ largest shareholder, Start-up Australia Ventures (“Start-up”), for its 28% stake in the company, follow on sell-down of Start-up’s stake to 8% and associated capital raising by Bionomics
15-Mar-11
$NA
Target:
CABB GmbH
Acquiror:
Bridgepoint Advisors Limited
Advised Bridgepoint Advisors Limited on the acquisition of CABB GmbH, a German global provider of fine and specialty chemicals and custom manufacturing solutions
15-Jan-11
$105 million
Target:
telerob Holding GmbH
Acquiror:
Cobham plc
Advised the shareholders of telerob Holding GmbH, a German-based market leader in the development and manufacture of advanced bomb disposal robots and integrated threat response vehicles, on the sale of the Company to Cobham plc, the UK-based, internationally operating aerospace, defence and security technology group
13-Dec-10
$256 million
Target:
Maxinutrition Group Holdings Limited
Acquiror:
GlaxoSmithKline Plc
Advised GlaxoSmithKline Plc, the UK listed international pharmaceutical and consumer company, on its acquisition of Maxinutrition Group Holdings Limited, a UK based sports nutrition business, from Darwin Private Equity
01-Dec-10
$100 million
Target:
Clyde Process Solutions plc
Acquiror:
S-Process Equipment International S.à r.l. (Schenck Process)
Advised S-Process Equipment International S.à r.l. (“Schenck Process”), a global leader in bulk material handling, providing applications incorporating weighing, feeding, screening and automation solutions, on its acquisition of Clyde Process Solutions plc, a global provider of pneumatic conveying and air filtration solutions for process industries
26-Nov-10
$118 million
Target:
Healthcare Australia
Acquiror:
Healthcare Locums
Advised CHAMP Private Equity on the sale of Healthcare Australia, a leading provider of nursing agency staff to public and private health institutions in Australia, to Healthcare Locums, a healthcare recruitment agency based in the UK
23-Sep-10
$394 million
Target:
Aevum Ltd.
Acquiror:
Stockland Corp. Ltd
Advised Aevum Limited, an ASX listed owner, operator and developer of retirement villages and aged care facilities on its response to a hostile takeover offer from Stockland Ltd, a global property development and investment management group
16-Sep-10
$NA
Target:
KemFine UK Ltd
Acquiror:
AURELIUS AG
Advised KemFine Group Oy, a 3i portfolio company, on the sale of its UK-based fine chemicals business, KemFine UK Ltd, to AURELIUS AG